Overexpression of miR-21 and miR-29 in Gastric Cancer Cell Line under Exposure to Extremely Low Frequency Electromagnetic Fields
Gastroenterology and Hepatology from Bed to Bench,
26 January 2021
Aim: In this study, was investigated the variation of miR-21 and miR-29 expressions in a cell line of gastric cancer exposed to low-frequency electromagnetic fields with 0.25 and 2.5 ml Tesla strength, in two type of continuous and discontinuous radiations.
- Gastric Cancer Cell Line
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
Waldum HL, Sagatun L, Mjqnes P. Gastrin and Gastric Cancer. Front Endocrinol 2017; 8(1): 1-7.
Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Gastroenterology Rev 2019; 14 (1): 26–38.
Zarea K, Beiranvand S, Ghanbari S, Hanna Tuvesson H. Incidence of Gastrointestinal Cancers in Iran: A Systematic Review. Jundishapur J Chronic Dis Care 2017; 6(1): e37224.
Larki P, Ahadi AR, Zare A, Tarighi S, Zaheri M, Souri M, et al. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer. Iranian Biomedical Journal 2018; 22 (6): 367-373.
Zeng Z, Wang J, Zhao L, Ping Hu P, Zhang H, Tang X, et al. Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis. Plos One 2013; 8(9): e73278.
Sarmasti Emami S, Nekouian R, Akbari A, Faraji A, Abbasi V, Shahram Agah S. Evaluation of circulating miR 21 and miR 222 as diagnostic biomarkers for gastric cancer. J Can Res Ther 2019; 15: 115-119.
Zhang Y, Guan DH, Bi RX, Xie J, Yang CH, Jiang YH. Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget 2017; 8(33): 55489-55510.
Zheng Q, Chen C, Guan H, Kang W, Yu C. Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis. Oncotarget 2017; 8 (28): 46611-46623.
Feng YH, Tsao CJ. Emerging role of microRNA-21 in cancer (Review). Biomedical Reports 2016; 5: 395-402.
Yang SM, Huang C, Li XF, Yu MZ, He Y, Li J. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology 2013; 306: 162-168.
Wang D, Fan Z, Liu F, Zuo J. Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer. Cell Physiol Biochem 2015; 37: 1454-1462.
Kwon JJ, Factora TD, Dey S, Kota J. A Systematic Review of miR-29 in Cancer. Oncolytics 2019; 173-194.
Han TS, Hur K, Xu G, Choi B, Okugawa Y, Toiyama Y, et al. MicroRNA-29c-mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut 2015; 64(2): 203–214.
Hwang J, Min BH, Jang J, Kang SY, Bae H, Jang SS, et al. MicroRNA Expression Profiles in Gastric Carcinogenesis. Scientific Reports 2018; 8: 14393.
Zhao X, Hou Y, Tuo Z, Wei F. Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer. Experimental and Therapeutic Medicine 2018; 15: 4179-4184.
Wang J, Qian Zhang Q, Wang D, Yan W, Sha H, Zhao J, et al. MiR-29a: a potential therapeutic target and promising biomarker in tumors. Bioscience Reports 2018; 38: 1-13.
Ren J, Ding L, Xu Q, Shi G, Li X, Li X, et al. LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1/E2F3 pathway. Scientific Reports 2017; 7(749): 1-12.
Xu Y, Wang Y, Yao A, Xu Z, Dou H, Shen S, et al. Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway. Scientific Reports 2017; 7 (11776): 1-14.
Pasi F, Fassina L, Mognaschi ME, Lupo G, Corbelia F, Nano R, et al. Pulsed Electromagnetic Field with Temozolomide Can Elicit an Epigenetic Pro-apoptotic Effect on Glioblastoma T98G Cells. Ant Cancer Research 2016; 36: 5821-5826.
Mattsson MO, Simkó M. Emerging medical applications based on non-ionizing electromagnetic fields from 0 Hz to 10 THz. Medical Devices: Eviden Res 2019; 12: 347–368.
Jimenez H, Blackman C, Lesser G, Debinski W, Chan M, Sharma S, et al. Use of non-ionizing electromagnetic fields for the treatment of cancer. History of Radio frequency electromagnetic fields (RF EMF). Front Bio sci 2018; 23:284–297.
Burri SH, Gondi V, Brown PD, Mehta MP. The evolving role of tumor treating fields in managing glioblastoma: guide for oncologists. Am J Clin Oncol Cancer Clin Trials 2018; 41(2):191–196.
Destefanis M, Viano M, Leo C, Gervino G, Ponzetto A, Silvagno F. Extremely low frequency electromagnetic fields affect proliferation and Mitochondrial activity of human cancer cell lines. International Journal of Radiation Biology 2015; 1101848: 1-9.
Sengupta S, Balla Vk. A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment. Journal of Advanced Research 2018; 14: 97–111
Falone S, Santini SJ, Cordone V, Emidio GD, Tatone C, Cacchio M, et al. Extremely low-frequency magnetic fields and Redox Responsive Pathways linked to Cancer Drug Resistance: Insigth from Co-exposure Based in Vitro Studies. Frontiers in Public Health 2018; 6(33): 1-16.
Liu Y, Liu W-b, Liu K-j, Ao L, Cao J, Zhong JL, et al. Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields, Cell Cycle 2016; 15(3): 357-367.
Liu Y, Liu W-b, Liu K-j, Ao L, Cao J, Zhong JL, et al. Extremely Low-Frequency Electromagnetic Fields affect the miRNA-Mediated Regulation of Signaling Pathways in the GC-2 Cell Line. Plos One 2015; 10(10): e0139949.
Erdal ME, Yılmaz SG, Gürgül S, Uzun C, Derici D, Erdal N. MiRNA expression profile is altered differentially in the rat brain compared to blood after experimental exposure to 50 Hz and 1 mT electromagnetic field. Progress in Biophysics and Molecular Biology 2018; 132: 35-42.
- Abstract Viewed: 0 times